Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Pomeranian Medical University Szczecin clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Poland, Germany, Denmark and Czechia registers with Pomeranian Medical University Szczecin as lead sponsor. Synced 16 Nov 2026
10Current trials
4Recruiting now
2Drugs in these trials
4Trial registers
At a glance

Pomeranian Medical University Szczecin is the lead sponsor of 10 current clinical trials in our Poland, Germany, Denmark and Czechia registers. 4 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Cabotegravir and Ceftriaxone. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting440%
  • Not yet open110%
  • Active, closed440%
  • By invitation110%

Trials by phase

  • Observational770%
  • Not applicable330%
01

Clinical trials sponsored by Pomeranian Medical University Szczecin

10 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
NCT07370649 · ClinicalTrials.gov ↗ · Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection
Observational Recruiting 2026-05 Germany, Poland, Czechia
Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients
NCT07308457 · ClinicalTrials.gov ↗ · Incidence of Infectious Diseases
Not applicable Recruiting 2024-09 Poland
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.
NCT06809101 · ClinicalTrials.gov ↗ · Cancer, Cancer-related Problem/Condition, Chemotherapy
Observational Recruiting 2025-03 Germany, Denmark, Poland
Evaluation of Visual Outcomes, Complications, and Neuroadaptation Following Bilateral Implantation of enVista Envy Trifocal Intraocular Lenses
NCT07696130 · ClinicalTrials.gov ↗ · Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
Not applicable Recruiting 2026-02 Poland
Metabolic Obesity in Normal Weight (MONW): Diagnostic Markers Stud
NCT07358533 · ClinicalTrials.gov ↗ · Normal Weight Obesity, Metabolically Obese Normal Weight, Metabolic Syndrome
Observational Not yet open 2026-09 Poland
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
NCT07165626 · ClinicalTrials.gov ↗ · Epiretinal Membrane, Macular Oedema, Macular Diseases
Not applicable By invitation 2024-05 Poland
Microanalysis of Changes in 3D Geometry of Orthodontic Mini-implants
NCT06743360 · ClinicalTrials.gov ↗ · Malocclusions, Malocclusion, Angle Class I, Malocclusion, Angle Class II
Observational Active, closed 2024-10 Poland
Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire
NCT06985004 · ClinicalTrials.gov ↗ · Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy
Observational Active, closed 2024-01 Poland
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
NCT06881329 · ClinicalTrials.gov ↗ · Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Cerebral Vasospasm After Subarachnoid Hemorrhage
Observational Active, closed 2021-12 Poland
Sagittal Spine Balance in Patients With Chest Wall Deformity
NCT07070609 · ClinicalTrials.gov ↗ · Scoliosis Idiopathic Adolescent, Chest Deformities
Observational Active, closed 2025-03 Poland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Pomeranian Medical University Szczecin trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Pomeranian Medical University Szczecin trials

29 conditions
Cancer1Cancer-related Problem/Condition1Chemotherapy1Chemotherapy-induced Neutropenia1Human Immunodeficiency Virus (HIV)-1 Infection1HIV-1 Subtype A6 Infection1HIV-1 Subtype B Infection1Virologically Suppressed HIV-1 Infection Receiving Long-Acting Antiretroviral Therapy1Incidence of Infectious Diseases1Normal Weight Obesity1Metabolically Obese Normal Weight1Metabolic Syndrome1Malocclusions1Malocclusion, Angle Class I1Malocclusion, Angle Class II1Prostate Cancer1Robot-Assisted Laparoscopic Radical Prostatectomy1Subarachnoid Hemorrhage, Aneurysmal1Delayed Cerebral Ischemia1Cerebral Vasospasm After Subarachnoid Hemorrhage1Intracranial Aneurysm1Scoliosis Idiopathic Adolescent1Chest Deformities1Epiretinal Membrane1
06

Questions about Pomeranian Medical University Szczecin trials

How many clinical trials does Pomeranian Medical University Szczecin sponsor?

Pomeranian Medical University Szczecin is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Poland, Germany, Denmark and Czechia registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are Pomeranian Medical University Szczecin trials recruiting?

Yes. 4 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Pomeranian Medical University Szczecin testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Cabotegravir (1) and Ceftriaxone (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.